Autologous Gene-edited Muscle Stem Cells Therapy(Universitätsmedizin Berlin)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameAutologous Gene-edited Muscle Stem Cells Therapy(Universitätsmedizin Berlin)

Drug Alias NameGenPHSats-bASKet(Universitätsmedizin Berlin)GenPHSat(Universitätsmedizin Berlin)LipiCell

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Muscle stem cell therapyCell and gene therapy > Gene therapy > Gene editingCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCharité – Universitätsmedizin Berlin

China Registration ClassN/A

Develop Information

Active CompaniesCharité – Universitätsmedizin Berlin

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophies, Limb-Girdle

Inactive IndicationsN/A

Other Information

ATC CodeN/A